Biostar Pharmaceuticals Inc. (“Biostar”) is a holding company that, through our wholly-owned subsidiary Shaanxi Biostar Biotech Ltd. (“Shaanxi Biostar”) and our variable interest entities (“VIEs”) Shaanxi Aoxing Pharmaceutical Co. Ltd. (“Aoxing Pharmaceutical”), and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (“Shaanxi Weinan”) develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the People’s Republic of China (the “PRC” or “China”).
Company profile
Ticker
BSPM
Exchange
Website
CEO
Rong Hua Wang
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
25-NSE
Exchange delisting
8 Jan 19
8-K
Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq
24 Aug 18
8-K
Biostar Pharmaceuticals Received Nasdaq Delisting Notification
25 Jul 18
8-K
Other Events
6 Jul 18
8-K
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
30 May 18
NT 10-Q
Notice of late quarterly filing
16 May 18
8-K
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
23 Apr 18
NT 10-K
Notice of late annual filing
2 Apr 18
8-K
Departure of Directors or Certain Officers
2 Feb 18
8-K
Changes in Registrant's Certifying Accountant
2 Feb 18
Institutional ownership, Q4 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|